Currently, there are 1.33B common shares owned by the public and among those 1.33B shares have been available to trade.
The company’s stock has a 5-day price change of -1.83% and 15.86% over the past three months. RTX shares are trading 18.87% year to date (YTD), with the 12-month market performance down to -1.63% lower. It has a 12-month low price of $68.56 and touched a high of $104.91 over the same period. RTX has an average intraday trading volume of 8.52 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.42%, 6.92%, and 16.44% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of RTX Corp (NYSE: RTX) shares accounts for 87.59% of the company’s 1.33B shares outstanding.
It has a market capitalization of $132.99B and a beta (3y monthly) value of 0.93. The stock’s trailing 12-month PE ratio is 44.68, while the earnings-per-share (ttm) stands at $2.24. The company has a PEG of 3.96 and a Quick Ratio of 0.78 with the debt-to-equity ratio at 0.76. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.89% over the week and 1.49% over the month.
Analysts forecast that RTX Corp (RTX) will achieve an EPS of $Vertex Pharmaceuticals Incorpor for the current quarter, $397.36 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Seagate Technology Holdings PLC while analysts give the company a high EPS estimate of $Heron Therapeutics, Inc.. Comparatively, EPS for the current quarter was $TRX Gold Corporation a year ago. Earnings per share for the fiscal year are expected to increase by 6.69%, and 14.03% over the next financial year. EPS should grow at an annualized rate of 11.29% over the next five years, compared to -19.30% over the past 5-year period.
Looking at the support for the RTX, a number of firms have released research notes about the stock. Wells Fargo stated their Overweight rating for the stock in a research note on March 14, 2024, with the firm’s price target at $100-$120. BofA Securities coverage for the RTX Corp (RTX) stock in a research note released on January 25, 2024 offered a Neutral rating with a price target of $100. DZ Bank on their part issued Sell rating on October 27, 2023.
